GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » VivoSim Labs Inc (LTS:0R02) » Definitions » Cyclically Adjusted PB Ratio

VivoSim Labs (LTS:0R02) Cyclically Adjusted PB Ratio : 0.04 (As of Jun. 03, 2025)


View and export this data going back to 2014. Start your Free Trial

What is VivoSim Labs Cyclically Adjusted PB Ratio?

As of today (2025-06-03), VivoSim Labs's current share price is $3.174. VivoSim Labs's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2024 was $88.80. VivoSim Labs's Cyclically Adjusted PB Ratio for today is 0.04.

The historical rank and industry rank for VivoSim Labs's Cyclically Adjusted PB Ratio or its related term are showing as below:

LTS:0R02' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.02   Med: 0.21   Max: 3.07
Current: 0.02

During the past years, VivoSim Labs's highest Cyclically Adjusted PB Ratio was 3.07. The lowest was 0.02. And the median was 0.21.

LTS:0R02's Cyclically Adjusted PB Ratio is ranked better than
97.62% of 672 companies
in the Biotechnology industry
Industry Median: 1.475 vs LTS:0R02: 0.02

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

VivoSim Labs's adjusted book value per share data for the three months ended in Dec. 2024 was $0.255. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $88.80 for the trailing ten years ended in Dec. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


VivoSim Labs Cyclically Adjusted PB Ratio Historical Data

The historical data trend for VivoSim Labs's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VivoSim Labs Cyclically Adjusted PB Ratio Chart

VivoSim Labs Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.28 1.49 0.47 0.22 0.11

VivoSim Labs Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.12 0.11 0.09 0.06 0.06

Competitive Comparison of VivoSim Labs's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, VivoSim Labs's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


VivoSim Labs's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, VivoSim Labs's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where VivoSim Labs's Cyclically Adjusted PB Ratio falls into.


;
;

VivoSim Labs Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

VivoSim Labs's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=3.174/88.80
=0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

VivoSim Labs's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2024 is calculated as:

For example, VivoSim Labs's adjusted Book Value per Share data for the three months ended in Dec. 2024 was:

Adj_Book=Book Value per Share/CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=0.255/133.1571*133.1571
=0.255

Current CPI (Dec. 2024) = 133.1571.

VivoSim Labs Quarterly Data

Book Value per Share CPI Adj_Book
201503 143.224 99.621 191.438
201506 221.608 100.684 293.082
201509 197.795 100.392 262.351
201512 179.322 99.792 239.277
201603 161.509 100.470 214.054
201606 142.449 101.688 186.532
201609 134.238 101.861 175.482
201612 163.373 101.863 213.565
201703 143.032 102.862 185.158
201706 129.862 103.349 167.317
201709 116.984 104.136 149.586
201712 106.581 104.011 136.447
201803 96.298 105.290 121.786
201806 87.619 106.317 109.739
201809 80.979 106.507 101.242
201812 72.658 105.998 91.275
201903 70.209 107.251 87.168
201906 66.554 108.070 82.004
201909 57.225 108.329 70.340
201912 53.224 108.420 65.368
202003 48.954 108.902 59.858
202006 45.563 108.767 55.780
202009 35.627 109.815 43.200
202012 34.995 109.897 42.402
202103 54.213 111.754 64.596
202106 51.490 114.631 59.811
202109 47.311 115.734 54.433
202112 43.163 117.630 48.861
202203 41.610 121.301 45.677
202206 38.091 125.017 40.571
202209 34.444 125.227 36.625
202212 30.701 125.222 32.647
202303 21.114 127.348 22.077
202306 16.198 128.729 16.755
202309 11.631 129.860 11.926
202312 7.539 129.419 7.757
202403 4.287 131.776 4.332
202406 5.561 132.554 5.586
202409 2.875 133.029 2.878
202412 0.255 133.157 0.255

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


VivoSim Labs  (LTS:0R02) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


VivoSim Labs Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of VivoSim Labs's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


VivoSim Labs Business Description

Industry
Traded in Other Exchanges
Address
11555 Sorrento Valley road, Suite 100, San Diego, CA, USA, 92121
VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases.

VivoSim Labs Headlines

No Headlines